시장조사보고서

세계의 당뇨병 약 시장 2018 Global Diabetes Drugs Market Research Report 2018

  • cover image
  • 상품 코드 : 375392
  • 리서치사 : QYResearch
  • 발행일 : 2018년 07월
  • 페이지 정보 : 영문 100 Pages
  • 배송 : 3~5 영업일 이내
  • 가격 :

요약

세계, 특히 북미, 유럽, 중국, 일본 등의 당뇨병 약 산업에 대해 조사했으며, 주요 제조업체 현황, 지역·제품 종류·용도별 시장 동향(생산량, 가격, 매출, 시장 점유율, 성장률 등) 분석/예측 결과를 정리하여 전해드립니다.

1 당뇨병 약 시장 개요

2 세계의 당뇨병 약 시장 경쟁 : 제조업체별

3 세계의 당뇨병 약 생산능력, 생산량, 매출(가격) : 지역별 (2013-2018)

4 Global 당뇨병 약 Supply (Production), Consumption, Export, Import by Region (2013-2018)

5 세계의 당뇨병 약 생산량, 매출(액수), 가격 동향 : 제품 종류별

6 세계의 당뇨병 약 시장 분석 : 용도별

7 당뇨병 약 제조업체 개요/분석

  • 7.1 Pfizer
  • 7.2 Sanofi
  • 7.3 Novartis
  • 7.4 Abbott
  • 7.5 GSK
  • 7.6 Merck
  • 7.7 Roche
  • 7.8 Eli Lilly
  • 7.9 B. Braun Melsungen
  • 7.10 AstraZeneca
  • 7.11 Bayer
  • 7.12 DexCom
  • 7.13 LTS
  • 7.14 J&J
  • 7.15 Indivior
  • 7.16 Johnson & Johnson

8 당뇨병 약 제조 비용 분석

9 산업체인, 구매 전략, 다운스트림(Downstream) 구매자

10 마케팅 전략 분석, 유통업체/수출입업체

11 시장 영향요인 분석

12 당뇨병 약 세계 시장 예측 (2018-2025)

13 조사 소견과 결론

14 부록


목차

This report studies the global Diabetes Drugs market status and forecast, categorizes the global Diabetes Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The global Diabetes Drugs market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major manufacturers covered in this report

  • Pfizer
  • Sanofi
  • Novartis
  • Abbott
  • GSK
  • Merck
  • Roche
  • Eli Lilly
  • B. Braun Melsungen
  • AstraZeneca
  • Bayer
  • DexCom
  • LTS
  • J&J
  • Indivior
  • Johnson & Johnson

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India

We can also provide the customized separate regional or country-level reports, for the following regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Singapore
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Central & South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • Turkey
    • Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

  • Sulphonylureas
  • Biguanides
  • Meglitinides
  • Thiazolidinediones
  • Alpha-glucosidase inhibitors
  • DPP-4 inhibitors
  • SGLT-2 inhibitors

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

  • Type I Diabetes
  • Type II Diabetes

The study objectives of this report are:

  • To analyze and study the global Diabetes Drugs sales, value, status (2013-2017) and forecast (2018-2025).
  • Focuses on the key Diabetes Drugs manufacturers, to study the sales, value, market share and development plans in future.
  • Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Diabetes Drugs are as follows:

  • History Year: 2013-2017
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Diabetes Drugs Manufacturers

Diabetes Drugs Distributors/Traders/Wholesalers

Diabetes Drugs Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Diabetes Drugs market, by end-use.

Detailed analysis and profiles of additional market players.

Table of Contents

1 Diabetes Drugs Market Overview

  • 1.1 Product Overview and Scope of Diabetes Drugs
  • 1.2 Diabetes Drugs Segment by Type (Product Category)
    • 1.2.1 Global Diabetes Drugs Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
    • 1.2.2 Global Diabetes Drugs Production Market Share by Type (Product Category) in 2017
    • 1.2.3 Sulphonylureas
    • 1.2.4 Biguanides
    • 1.2.5 Meglitinides
    • 1.2.6 Thiazolidinediones
    • 1.2.7 Alpha-glucosidase inhibitors
    • 1.2.8 DPP-4 inhibitors
    • 1.2.9 SGLT-2 inhibitors
  • 1.3 Global Diabetes Drugs Segment by Application
    • 1.3.1 Diabetes Drugs Consumption (Sales) Comparison by Application (2013-2025)
    • 1.3.2 Type I Diabetes
    • 1.3.3 Type II Diabetes
  • 1.4 Global Diabetes Drugs Market by Region (2013-2025)
    • 1.4.1 Global Diabetes Drugs Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
    • 1.4.2 North America Status and Prospect (2013-2025)
    • 1.4.3 Europe Status and Prospect (2013-2025)
    • 1.4.4 China Status and Prospect (2013-2025)
    • 1.4.5 Japan Status and Prospect (2013-2025)
    • 1.4.6 Southeast Asia Status and Prospect (2013-2025)
    • 1.4.7 India Status and Prospect (2013-2025)
  • 1.5 Global Market Size (Value) of Diabetes Drugs (2013-2025)
    • 1.5.1 Global Diabetes Drugs Revenue Status and Outlook (2013-2025)
    • 1.5.2 Global Diabetes Drugs Capacity, Production Status and Outlook (2013-2025)

2 Global Diabetes Drugs Market Competition by Manufacturers

  • 2.1 Global Diabetes Drugs Capacity, Production and Share by Manufacturers (2013-2018)
    • 2.1.1 Global Diabetes Drugs Capacity and Share by Manufacturers (2013-2018)
    • 2.1.2 Global Diabetes Drugs Production and Share by Manufacturers (2013-2018)
  • 2.2 Global Diabetes Drugs Revenue and Share by Manufacturers (2013-2018)
  • 2.3 Global Diabetes Drugs Average Price by Manufacturers (2013-2018)
  • 2.4 Manufacturers Diabetes Drugs Manufacturing Base Distribution, Sales Area and Product Type
  • 2.5 Diabetes Drugs Market Competitive Situation and Trends
    • 2.5.1 Diabetes Drugs Market Concentration Rate
    • 2.5.2 Diabetes Drugs Market Share of Top 3 and Top 5 Manufacturers
    • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Diabetes Drugs Capacity, Production, Revenue (Value) by Region (2013-2018)

  • 3.1 Global Diabetes Drugs Capacity and Market Share by Region (2013-2018)
  • 3.2 Global Diabetes Drugs Production and Market Share by Region (2013-2018)
  • 3.3 Global Diabetes Drugs Revenue (Value) and Market Share by Region (2013-2018)
  • 3.4 Global Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  • 3.5 North America Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  • 3.6 Europe Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  • 3.7 China Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  • 3.8 Japan Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  • 3.9 Southeast Asia Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  • 3.10 India Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Diabetes Drugs Supply (Production), Consumption, Export, Import by Region (2013-2018)

  • 4.1 Global Diabetes Drugs Consumption by Region (2013-2018)
  • 4.2 North America Diabetes Drugs Production, Consumption, Export, Import (2013-2018)
  • 4.3 Europe Diabetes Drugs Production, Consumption, Export, Import (2013-2018)
  • 4.4 China Diabetes Drugs Production, Consumption, Export, Import (2013-2018)
  • 4.5 Japan Diabetes Drugs Production, Consumption, Export, Import (2013-2018)
  • 4.6 Southeast Asia Diabetes Drugs Production, Consumption, Export, Import (2013-2018)
  • 4.7 India Diabetes Drugs Production, Consumption, Export, Import (2013-2018)

5 Global Diabetes Drugs Production, Revenue (Value), Price Trend by Type

  • 5.1 Global Diabetes Drugs Production and Market Share by Type (2013-2018)
  • 5.2 Global Diabetes Drugs Revenue and Market Share by Type (2013-2018)
  • 5.3 Global Diabetes Drugs Price by Type (2013-2018)
  • 5.4 Global Diabetes Drugs Production Growth by Type (2013-2018)

6 Global Diabetes Drugs Market Analysis by Application

  • 6.1 Global Diabetes Drugs Consumption and Market Share by Application (2013-2018)
  • 6.2 Global Diabetes Drugs Consumption Growth Rate by Application (2013-2018)
  • 6.3 Market Drivers and Opportunities
    • 6.3.1 Potential Applications
    • 6.3.2 Emerging Markets/Countries

7 Global Diabetes Drugs Manufacturers Profiles/Analysis

  • 7.1 Pfizer
    • 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 7.1.2 Diabetes Drugs Product Category, Application and Specification
      • 7.1.2.1 Product A
      • 7.1.2.2 Product B
    • 7.1.3 Pfizer Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 7.1.4 Main Business/Business Overview
  • 7.2 Sanofi
    • 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 7.2.2 Diabetes Drugs Product Category, Application and Specification
      • 7.2.2.1 Product A
      • 7.2.2.2 Product B
    • 7.2.3 Sanofi Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 7.2.4 Main Business/Business Overview
  • 7.3 Novartis
    • 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 7.3.2 Diabetes Drugs Product Category, Application and Specification
      • 7.3.2.1 Product A
      • 7.3.2.2 Product B
    • 7.3.3 Novartis Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 7.3.4 Main Business/Business Overview
  • 7.4 Abbott
    • 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 7.4.2 Diabetes Drugs Product Category, Application and Specification
      • 7.4.2.1 Product A
      • 7.4.2.2 Product B
    • 7.4.3 Abbott Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 7.4.4 Main Business/Business Overview
  • 7.5 GSK
    • 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 7.5.2 Diabetes Drugs Product Category, Application and Specification
      • 7.5.2.1 Product A
      • 7.5.2.2 Product B
    • 7.5.3 GSK Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
    • 7.5.4 Main Business/Business Overview
  • 7.6 Merck
    • 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 7.6.2 Diabetes Drugs Product Category, Application and Specification
      • 7.6.2.1 Product A
      • 7.6.2.2 Product B
    • 7.6.3 Merck Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 7.6.4 Main Business/Business Overview
  • 7.7 Roche
    • 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 7.7.2 Diabetes Drugs Product Category, Application and Specification
      • 7.7.2.1 Product A
      • 7.7.2.2 Product B
    • 7.7.3 Roche Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 7.7.4 Main Business/Business Overview
  • 7.8 Eli Lilly
    • 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 7.8.2 Diabetes Drugs Product Category, Application and Specification
      • 7.8.2.1 Product A
      • 7.8.2.2 Product B
    • 7.8.3 Eli Lilly Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 7.8.4 Main Business/Business Overview
  • 7.9 B. Braun Melsungen
    • 7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 7.9.2 Diabetes Drugs Product Category, Application and Specification
      • 7.9.2.1 Product A
      • 7.9.2.2 Product B
    • 7.9.3 B. Braun Melsungen Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
    • 7.9.4 Main Business/Business Overview
  • 7.10 AstraZeneca
    • 7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    • 7.10.2 Diabetes Drugs Product Category, Application and Specification
      • 7.10.2.1 Product A
      • 7.10.2.2 Product B
    • 7.10.3 AstraZeneca Diabetes Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2020)
    • 7.10.4 Main Business/Business Overview
  • 7.11 Bayer
  • 7.12 DexCom
  • 7.13 LTS
  • 7.14 J&J
  • 7.15 Indivior
  • 7.16 Johnson & Johnson

8 Diabetes Drugs Manufacturing Cost Analysis

  • 8.1 Diabetes Drugs Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Price Trend of Key Raw Materials
    • 8.1.3 Key Suppliers of Raw Materials
    • 8.1.4 Market Concentration Rate of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
    • 8.2.1 Raw Materials
    • 8.2.2 Labor Cost
    • 8.2.3 Manufacturing Expenses
  • 8.3 Manufacturing Process Analysis of Diabetes Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

  • 9.1 Diabetes Drugs Industrial Chain Analysis
  • 9.2 Upstream Raw Materials Sourcing
  • 9.3 Raw Materials Sources of Diabetes Drugs Major Manufacturers in 2017
  • 9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

  • 10.1 Marketing Channel
    • 10.1.1 Direct Marketing
    • 10.1.2 Indirect Marketing
    • 10.1.3 Marketing Channel Development Trend
  • 10.2 Market Positioning
    • 10.2.1 Pricing Strategy
    • 10.2.2 Brand Strategy
    • 10.2.3 Target Client
  • 10.3 Distributors/Traders List

11 Market Effect Factors Analysis

  • 11.1 Technology Progress/Risk
    • 11.1.1 Substitutes Threat
    • 11.1.2 Technology Progress in Related Industry
  • 11.2 Consumer Needs/Customer Preference Change
  • 11.3 Economic/Political Environmental Change

12 Global Diabetes Drugs Market Forecast (2018-2025)

  • 12.1 Global Diabetes Drugs Capacity, Production, Revenue Forecast (2018-2025)
    • 12.1.1 Global Diabetes Drugs Capacity, Production and Growth Rate Forecast (2018-2025)
    • 12.1.2 Global Diabetes Drugs Revenue and Growth Rate Forecast (2018-2025)
    • 12.1.3 Global Diabetes Drugs Price and Trend Forecast (2018-2025)
  • 12.2 Global Diabetes Drugs Production, Consumption , Import and Export Forecast by Region (2018-2025)
    • 12.2.1 North America Diabetes Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
    • 12.2.2 Europe Diabetes Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
    • 12.2.3 China Diabetes Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
    • 12.2.4 Japan Diabetes Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
    • 12.2.5 Southeast Asia Diabetes Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
    • 12.2.6 India Diabetes Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  • 12.3 Global Diabetes Drugs Production, Revenue and Price Forecast by Type (2018-2025)
  • 12.4 Global Diabetes Drugs Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix

  • 14.1 Methodology/Research Approach
    • 14.1.1 Research Programs/Design
    • 14.1.2 Market Size Estimation
    • 14.1.3 Market Breakdown and Data Triangulation
  • 14.2 Data Source
    • 14.2.1 Secondary Sources
    • 14.2.2 Primary Sources
  • 14.3 Disclaimer

List of Tables and Figures

  • Figure Picture of Diabetes Drugs
  • Figure Global Diabetes Drugs Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
  • Figure Global Diabetes Drugs Production Market Share by Types (Product Category) in 2017
  • Figure Product Picture of Sulphonylureas
  • Table Major Manufacturers of Sulphonylureas
  • Figure Product Picture of Biguanides
  • Table Major Manufacturers of Biguanides
  • Figure Product Picture of Meglitinides
  • Table Major Manufacturers of Meglitinides
  • Figure Product Picture of Thiazolidinediones
  • Table Major Manufacturers of Thiazolidinediones
  • Figure Product Picture of Alpha-glucosidase inhibitors
  • Table Major Manufacturers of Alpha-glucosidase inhibitors
  • Figure Product Picture of DPP-4 inhibitors
  • Table Major Manufacturers of DPP-4 inhibitors
  • Figure Product Picture of SGLT-2 inhibitors
  • Table Major Manufacturers of SGLT-2 inhibitors
  • Figure Global Diabetes Drugs Consumption (K Units) by Applications (2013-2025)
  • Figure Global Diabetes Drugs Consumption Market Share by Applications in 2017
  • Figure Type I Diabetes Examples
  • Table Key Downstream Customer in Type I Diabetes
  • Figure Type II Diabetes Examples
  • Table Key Downstream Customer in Type II Diabetes
  • Figure Global Diabetes Drugs Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)
  • Figure North America Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure Europe Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure China Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure Japan Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure Southeast Asia Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure India Diabetes Drugs Revenue (Million USD) and Growth Rate (2013-2025)
  • Figure Global Diabetes Drugs Revenue (Million USD) Status and Outlook (2013-2025)
  • Figure Global Diabetes Drugs Capacity, Production (K Units) Status and Outlook (2013-2025)
  • Figure Global Diabetes Drugs Major Players Product Capacity (K Units) (2013-2018)
  • Table Global Diabetes Drugs Capacity (K Units) of Key Manufacturers (2013-2018)
  • Table Global Diabetes Drugs Capacity Market Share of Key Manufacturers (2013-2018)
  • Figure Global Diabetes Drugs Capacity (K Units) of Key Manufacturers in 2017
  • Figure Global Diabetes Drugs Capacity (K Units) of Key Manufacturers in 2018
  • Figure Global Diabetes Drugs Major Players Product Production (K Units) (2013-2018)
  • Table Global Diabetes Drugs Production (K Units) of Key Manufacturers (2013-2018)
  • Table Global Diabetes Drugs Production Share by Manufacturers (2013-2018)
  • Figure 2017 Diabetes Drugs Production Share by Manufacturers
  • Figure 2017 Diabetes Drugs Production Share by Manufacturers
  • Figure Global Diabetes Drugs Major Players Product Revenue (Million USD) (2013-2018)
  • Table Global Diabetes Drugs Revenue (Million USD) by Manufacturers (2013-2018)
  • Table Global Diabetes Drugs Revenue Share by Manufacturers (2013-2018)
  • Table 2017 Global Diabetes Drugs Revenue Share by Manufacturers
  • Table 2018 Global Diabetes Drugs Revenue Share by Manufacturers
  • Table Global Market Diabetes Drugs Average Price (USD/Unit) of Key Manufacturers (2013-2018)
  • Figure Global Market Diabetes Drugs Average Price (USD/Unit) of Key Manufacturers in 2017
  • Table Manufacturers Diabetes Drugs Manufacturing Base Distribution and Sales Area
  • Table Manufacturers Diabetes Drugs Product Category
  • Figure Diabetes Drugs Market Share of Top 3 Manufacturers
  • Figure Diabetes Drugs Market Share of Top 5 Manufacturers
  • Table Global Diabetes Drugs Capacity (K Units) by Region (2013-2018)
  • Figure Global Diabetes Drugs Capacity Market Share by Region (2013-2018)
  • Figure Global Diabetes Drugs Capacity Market Share by Region (2013-2018)
  • Figure 2017 Global Diabetes Drugs Capacity Market Share by Region
  • Table Global Diabetes Drugs Production by Region (2013-2018)
  • Figure Global Diabetes Drugs Production (K Units) by Region (2013-2018)
  • Figure Global Diabetes Drugs Production Market Share by Region (2013-2018)
  • Figure 2017 Global Diabetes Drugs Production Market Share by Region
  • Table Global Diabetes Drugs Revenue (Million USD) by Region (2013-2018)
  • Table Global Diabetes Drugs Revenue Market Share by Region (2013-2018)
  • Figure Global Diabetes Drugs Revenue Market Share by Region (2013-2018)
  • Table 2017 Global Diabetes Drugs Revenue Market Share by Region
  • Figure Global Diabetes Drugs Capacity, Production (K Units) and Growth Rate (2013-2018)
  • Table Global Diabetes Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table North America Diabetes Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Europe Diabetes Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table China Diabetes Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Japan Diabetes Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table China Diabetes Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Japan Diabetes Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Global Diabetes Drugs Consumption (K Units) Market by Region (2013-2018)
  • Table Global Diabetes Drugs Consumption Market Share by Region (2013-2018)
  • Figure Global Diabetes Drugs Consumption Market Share by Region (2013-2018)
  • Figure 2017 Global Diabetes Drugs Consumption (K Units) Market Share by Region
  • Table North America Diabetes Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
  • Table Europe Diabetes Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
  • Table China Diabetes Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
  • Table Japan Diabetes Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
  • Table Southeast Asia Diabetes Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
  • Table India Diabetes Drugs Production, Consumption, Import & Export (K Units) (2013-2018)
  • Table Global Diabetes Drugs Production (K Units) by Type (2013-2018)
  • Table Global Diabetes Drugs Production Share by Type (2013-2018)
  • Figure Production Market Share of Diabetes Drugs by Type (2013-2018)
  • Figure 2017 Production Market Share of Diabetes Drugs by Type
  • Table Global Diabetes Drugs Revenue (Million USD) by Type (2013-2018)
  • Table Global Diabetes Drugs Revenue Share by Type (2013-2018)
  • Figure Production Revenue Share of Diabetes Drugs by Type (2013-2018)
  • Figure 2017 Revenue Market Share of Diabetes Drugs by Type
  • Table Global Diabetes Drugs Price (USD/Unit) by Type (2013-2018)
  • Figure Global Diabetes Drugs Production Growth by Type (2013-2018)
  • Table Global Diabetes Drugs Consumption (K Units) by Application (2013-2018)
  • Table Global Diabetes Drugs Consumption Market Share by Application (2013-2018)
  • Figure Global Diabetes Drugs Consumption Market Share by Applications (2013-2018)
  • Figure Global Diabetes Drugs Consumption Market Share by Application in 2017
  • Table Global Diabetes Drugs Consumption Growth Rate by Application (2013-2018)
  • Figure Global Diabetes Drugs Consumption Growth Rate by Application (2013-2018)
  • Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Pfizer Diabetes Drugs Capacity, Production (K Units), Revenue (Million USD), Price (Pfizer) and Gross Margin (2013-2018)
  • Figure Pfizer Diabetes Drugs Production Growth Rate (2013-2018)
  • Figure Pfizer Diabetes Drugs Production Market Share (2013-2018)
  • Figure Pfizer Diabetes Drugs Revenue Market Share (2013-2018)
  • Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Sanofi Diabetes Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Sanofi Diabetes Drugs Production Growth Rate (2013-2018)
  • Figure Sanofi Diabetes Drugs Production Market Share (2013-2018)
  • Figure Sanofi Diabetes Drugs Revenue Market Share (2013-2018)
  • Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Novartis Diabetes Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Novartis Diabetes Drugs Production Growth Rate (2013-2018)
  • Figure Novartis Diabetes Drugs Production Market Share (2013-2018)
  • Figure Novartis Diabetes Drugs Revenue Market Share (2013-2018)
  • Table Abbott Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Abbott Diabetes Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Abbott Diabetes Drugs Production Growth Rate (2013-2018)
  • Figure Abbott Diabetes Drugs Production Market Share (2013-2018)
  • Figure Abbott Diabetes Drugs Revenue Market Share (2013-2018)
  • Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table GSK Diabetes Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure GSK Diabetes Drugs Production Growth Rate (2013-2018)
  • Figure GSK Diabetes Drugs Production Market Share (2013-2018)
  • Figure GSK Diabetes Drugs Revenue Market Share (2013-2018)
  • Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Merck Diabetes Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Merck Diabetes Drugs Production Growth Rate (2013-2018)
  • Figure Merck Diabetes Drugs Production Market Share (2013-2018)
  • Figure Merck Diabetes Drugs Revenue Market Share (2013-2018)
  • Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Roche Diabetes Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Roche Diabetes Drugs Production Growth Rate (2013-2018)
  • Figure Roche Diabetes Drugs Production Market Share (2013-2018)
  • Figure Roche Diabetes Drugs Revenue Market Share (2013-2018)
  • Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table Eli Lilly Diabetes Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Eli Lilly Diabetes Drugs Production Growth Rate (2013-2018)
  • Figure Eli Lilly Diabetes Drugs Production Market Share (2013-2018)
  • Figure Eli Lilly Diabetes Drugs Revenue Market Share (2013-2018)
  • Table B. Braun Melsungen Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table B. Braun Melsungen Diabetes Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure B. Braun Melsungen Diabetes Drugs Production Growth Rate (2013-2018)
  • Figure B. Braun Melsungen Diabetes Drugs Production Market Share (2013-2018)
  • Figure B. Braun Melsungen Diabetes Drugs Revenue Market Share (2013-2018)
  • Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Table AstraZeneca Diabetes Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure AstraZeneca Diabetes Drugs Production Growth Rate (2013-2018)
  • Figure AstraZeneca Diabetes Drugs Production Market Share (2013-2018)
  • Figure AstraZeneca Diabetes Drugs Revenue Market Share (2013-2018)
  • Table Production Base and Market Concentration Rate of Raw Material
  • Figure Price Trend of Key Raw Materials
  • Table Key Suppliers of Raw Materials
  • Figure Manufacturing Cost Structure of Diabetes Drugs
  • Figure Manufacturing Process Analysis of Diabetes Drugs
  • Figure Diabetes Drugs Industrial Chain Analysis
  • Table Raw Materials Sources of Diabetes Drugs Major Manufacturers in 2017
  • Table Major Buyers of Diabetes Drugs
  • Table Distributors/Traders List
  • Figure Global Diabetes Drugs Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)
  • Figure Global Diabetes Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Figure Global Diabetes Drugs Price (Million USD) and Trend Forecast (2018-2025)
  • Table Global Diabetes Drugs Production (K Units) Forecast by Region (2018-2025)
  • Figure Global Diabetes Drugs Production Market Share Forecast by Region (2018-2025)
  • Table Global Diabetes Drugs Consumption (K Units) Forecast by Region (2018-2025)
  • Figure Global Diabetes Drugs Consumption Market Share Forecast by Region (2018-2025)
  • Figure North America Diabetes Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
  • Figure North America Diabetes Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Table North America Diabetes Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
  • Figure Europe Diabetes Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
  • Figure Europe Diabetes Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Table Europe Diabetes Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
  • Figure China Diabetes Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
  • Figure China Diabetes Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Table China Diabetes Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
  • Figure Japan Diabetes Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
  • Figure Japan Diabetes Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Table Japan Diabetes Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
  • Figure Southeast Asia Diabetes Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
  • Figure Southeast Asia Diabetes Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Table Southeast Asia Diabetes Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
  • Figure India Diabetes Drugs Production (K Units) and Growth Rate Forecast (2018-2025)
  • Figure India Diabetes Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
  • Table India Diabetes Drugs Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
  • Table Global Diabetes Drugs Production (K Units) Forecast by Type (2018-2025)
  • Figure Global Diabetes Drugs Production (K Units) Forecast by Type (2018-2025)
  • Table Global Diabetes Drugs Revenue (Million USD) Forecast by Type (2018-2025)
  • Figure Global Diabetes Drugs Revenue Market Share Forecast by Type (2018-2025)
  • Table Global Diabetes Drugs Price Forecast by Type (2018-2025)
  • Table Global Diabetes Drugs Consumption (K Units) Forecast by Application (2018-2025)
  • Figure Global Diabetes Drugs Consumption (K Units) Forecast by Application (2018-2025)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Source

당뇨병 약 관련자료

TOP
회사소개 이용약관 개인정보 처리방침 사이트맵

© Copyright 2011-2018, Global Information, Inc. All rights reserved.